The Mission of Death Clock

Welcome to another episode of Death Clock. I am your host, Brent Franson. Today's just going to be a solo episode. I wanted to share some things that I've learned over the past few years, try to summarize a bunch of what we know about preventative health into a single episode, and give an update on my own health situation, as well as the company, Death Clock, and the app.

So we've done about 100 episodes of this podcast. The first half were predominantly mental health related, and the second half or last 30% have been very much related to longevity. Our goal on the podcast is to bring in the most credentialed people we can on a given topic and ask them questions to understand that topic.

So we've done episodes on heart disease, bone health, and GLP-1s. You name it, we've really hit most of the major topics in mental health, physical health, and longevity. We take an approach of siding with the researchers; almost everybody has been an MD or a PhD at a top-tier institution here in the US, with decades of experience researching a particular topic.

There's a bunch of really bad information on TikTok, Instagram, and online related to health. While these experts are not always going to be right, deferring to the expertise of people who have been studying these topics for decades and have peer-reviewed research and validation of their work is the way to go.

We're going to continue in that theme to bring you the best people we can find to give us the ground truth on any particular topic. I'll start by sharing a little bit of what I see as the need for Death Clock, and it's a little bit grim.

I'll be a little bit aggressive about it, but basically, our healthcare system is not a healthcare system—it's a sick-care system. It is not equipped to help us prevent getting a disease in the first place, particularly these chronic diseases that are the top killers: heart disease, diabetes, obesity, cancer, Alzheimer's, and dementia. We are on our own, and even our primary care docs are not in a good position.

The average length of a visit for a primary care doctor—the doctor you would go see when you need antibiotics—is about 15 minutes (just under 16 minutes). That's enough time to have a short conversation with a patient and then prescribe them a medication or refer them to a specialist.

That is not enough time to understand the full picture of a person's health and think through their needs related to sleep, diet, exercise, screenings, and all the things we need to do to stay on top of preventative health. That's why we see such high rates of chronic disease in the US.

This is true of most Western countries, but it's particularly pronounced in the US. Over 70% of Americans have at least one chronic disease, and rates of diabetes and obesity are in the mid-30s to low-40s. These diseases are preventable. When it comes to the best treatment—preventing ourselves from getting the disease in the first place—we are either on our own to take preventative measures, or we get the diseases, unless we're part of the small percentage of people who are just lucky.

We have good genes, organically eat the right things, are pretty active, and basically got lucky. That's what we're trying to build with Death Clock. In a world post large language models, we can create scalable technology that helps anybody manage their preventative health in a hyper-personalized way.

It's a glaring need. Our mission is to help 100 million people live ten years longer. That 100 million is not just a big, arbitrary number that Silicon Valley companies throw out. As an entrepreneur building this company, if what we're doing can scale to 100 million people, the tech is doing most of the heavy lifting, which means we can keep the price point low.

The number one factor that determines life expectancy today is how much money you have. The top 1% live longer than the 99th percentile, who live longer than the 90th percentile, and so on. There's about a 15-year difference in life expectancy between the bottom 1% and the top 1%.

We want to build a tool that helps anybody live longer. The reason the top 1% live longer is multifactorial, but the number one reason is access to better healthcare. When you have money, one of the things you can spend it on is private doctors.

It's a good use of money to say, "Our healthcare system doesn't have me covered when it comes to preventative health. I'm going to pay a private doctor between $10,000 and $250,000 or $500,000 a year."

They get high-quality healthcare by stepping outside the system. When people get enough money, they buy time.

That's what a private jet is—a time machine. You're buying time and quality of time. Private doctors are a way to buy time. You're going to be healthier, live longer, and have a better quality of life.

The reason our mission is to help 100 million people live ten years longer is that we want to help a lot of people and avoid becoming a solution that is only helpful for a small number of affluent people who can already solve these issues.

We want to put that high-quality, preventative health experience into anybody's hands at a fraction of the cost. We're trying to fill the hole in preventative health by building a tool actually focused on healthcare that anyone globally can use.

We have users in over 100 countries. The rate at which people have tried Death Clock internationally has been much higher than expected.

We started this journey a year ago, and it's been a wild ride with more success than we imagined, though there's still a long way to go. Now, let's talk about what we've learned about preventative health that everyone should know.

There is an unfortunate reality for both mental and physical health: almost all roads lead to sleep, diet, and exercise. In our conversations with experts about psychopathy, bipolar, depression, diabetes, cancer, or heart disease, sleep, diet, and exercise are central.

The best thing you can do is sleep, eat well, and exercise. You can't get around those basic facts. To give some credit to our healthcare system, it is reactive because sleep, diet, and exercise are really hard to change at scale. Until GLP-1s like Ozempic and Wegovy, we haven't had a great answer for managing lifestyle habits.

They prescribe pills or procedures because that's what works at scale. If you had to prioritize those three things, you would prioritize them in exact order: sleep, diet, exercise. Sleep sits at number one because it has a cascading effect on the other two.

Convincing ourselves to do things that do not have an immediate benefit is hard. When you drink a beer, you feel relaxed immediately. When you exercise, you feel better at the end, but you feel worse the moment you start.

Eating the right food, exercising, or going to bed early lacks immediate gratification, requiring willpower, which is a finite resource. The better you sleep, the more willpower you have.

If you get high-quality, adequate sleep with a good wind-down routine, it becomes much easier the next day to eat the right things and convince yourself to work out.

Think of a time you've been hungover: it's very easy to eat fast food and skip exercising. That's why sleep sits at the top of the mountain. Focus on getting sleep right first, and the other two will follow.

Second, make it easy on yourself—it's a marathon, not a sprint. The classic January 1st mistake is trying to change your whole life in one day, which doesn't work. If you're sleeping six hours a night and going to bed at irregular times, don't worry about the total hours yet. Just try going to bed at the same time every night.

Once you master that, try going to bed an hour earlier. It's a slow change process, which is why popular books like Atomic Habits focus on tiny changes, or like the movie What About Bob?, it's about baby steps.

Focus on progress over perfection and practice self-compassion. Falling off the wagon is part of a successful change process.

Often, we view setbacks as failure and give up. But failing is a part of succeeding. The difference between people who succeed long-term and those who don't is that successful people don't view failure as a permanent setback.

You can say, "I stayed up late tonight, but tomorrow night I'm going to get back on track." People who succeed don't avoid failure; they just don't let failure stop them from continuing.

As an entrepreneur, I can tell you that entrepreneurship is tons of failure until one day it looks like success. Entrepreneurs get used to getting knocked down and getting back up until things start moving in their direction.

Things eventually go in your direction instead of against you.

Sleep, diet, exercise, progress over perfection, and baby steps really matter. Have compassion for yourself because it's hard work. Now, let's talk about physical health and screening categories.

When we think about cancer, we want to catch and treat it early. Beyond sleep, diet, and exercise, we need to be good about knowing what's happening in our bodies through screenings.

In screening, there are a few categories. First is the essential set of screenings.

This includes the colonoscopy. The US Preventive Services Task Force, the gold standard for screening recommendations, recommends your first colonoscopy at age 45 (lowered from age 50). People globally are getting colon cancer younger and developing more aggressive forms.

If you have an immediate family member who had colon cancer, get screened ten years prior to the age of their diagnosis. Even age 45 might not be young enough based on our podcast discussions.

The issue is getting it covered by insurance before 45 without family history or symptoms, as out-of-pocket costs are high.

In your 30s or mid-30s, you can do a stool test like Cologuard, where a sample is analyzed.

When these tests are negative, they are highly accurate at ruling out issues. If it comes back positive, it doesn't mean you have colon cancer, but it makes it much easier to get a colonoscopy covered by insurance.

Colorectal screening is essential. Consider stool tests in your mid-30s, but nothing replaces the gold-standard colonoscopy. The second screening is mammograms for women. This can be more complex depending on tissue density or genetic mutations like BRCA.

Consider the consider the fecal screen and then nothing is a replacement for the gold standard colonoscopy. The second set would be mammograms for women. These can be a little bit more complicated. It depends on the the density of your breast tissue. If you are genetically predisposed, if you're if you have the bracken mutation, you're going to think about this very differently.

Take breast cancer screening very seriously if you are biologically female. Prostate cancer screening also falls into this vital category, though it requires careful consideration due to risks of overtreatment from surgery or radiation.

The US Preventive Services Task Force recommends a PSA blood test between ages 50 and 70 to check prostate-specific antigen levels and decide if deeper screening is needed. They don't routinely recommend it after 70 because many men die with prostate cancer rather than from it, as it can be slow-growing.

Prostate cancer can be aggressive, so while you should be educated about overtreatment, you shouldn't be completely blind to your PSA levels before 50 or after 70.

The next category is skin cancer screening with a dermatologist. The US Preventive Services Task Force lacks a firm recommendation here because population data on mortality reduction is inconclusive, but annual skin exams are simple and effective for removing basal cell, squamous cell, or early melanoma.

Getting annual skin checks starting in your 20s is good preventative practice. Two other key screenings are for lung and cervical cancer.

Lung cancer screening via low-dose CT scan is recommended for adults aged 50 to 80 with a history of heavy smoking. Progressive longevity experts like Peter Attia suggest low-dose CT scans more broadly, as non-smokers can also develop lung cancer.

Catching it early is critical. For cervical cancer, sexually active women under 65 should get a Pap smear and HPV test every three years.

Basic screenings are essential. Now, let's address newer technologies, such as full-body MRI scans. Prominent medical societies and guidelines generally do not recommend full-body scans for asymptomatic individuals.

There isn't strong research showing that full-body scans on asymptomatic people improve overall mortality rates.

The math of screening is tricky. If you scan 1,000,000 asymptomatic people, you will save some lives by finding early disease, but you will also harm others through incidental findings and unnecessary procedures.

We interviewed Dr. Otis Brawley, an oncologist who served on the US Preventive Services Task Force panel that lowered the colon cancer screening age from 50 to 45.

He discussed lung screening studies where groups screened beyond guidelines actually experienced higher overall mortality.

This happens because scans often find ambiguous nodules or incidentalomas. A benign lung nodule might require a biopsy, leading to complications like a collapsed lung or cardiac event during the diagnostic process.

You'll hear that term. But it's really ambiguous results. Which means hey there's a nodule on your lung. We found an ongoing lung. We don't know if it's benign or not. A lot of people have nodules on their lungs that are totally normal and benign. But sometimes there's a nodule on the lung that's lung cancer. The process of determining whether or not the nodule on the lung is lung cancer involves taking a piece of tissue off of that nodule, and people in those diagnostic procedures can have their lungs can collapse, or they have heart attacks.

Diagnostics can be a slippery slope. Full-body scans carry a high rate of ambiguous findings that lead to psychological distress and invasive follow-ups.

Subsequent tests to investigate incidental findings carry real risks.

At the population level, the benefits of full-body scans remain unproven. Be skeptical of anyone marketing them as an essential preventative tool without discussing the trade-offs.

Get educated before making a decision. Full-body scans are very different from standard, proven screenings like colonoscopies.

Be an informed consumer when considering elective medical scans.

Another emerging tool is liquid biopsy—blood tests that screen for circulating tumor DNA.

A negative result simply means "no cancer detected," not a guarantee that you are cancer-free. These tests also present challenges with ambiguous findings where cancer signals are detected without a clear primary site.

Now let's talk about heart screenings. The most common heart scan is a CT calcium scan (coronary artery calcium scan). It uses a low-dose 3D CT scan of the chest to detect calcified plaque in the coronary arteries.

Dr. Arthur Agatston, developer of the calcium score, has been on our podcast. Calcified plaque is hard, stable plaque. It's actually less prone to sudden rupture than soft, non-calcified plaque, but a calcium score above zero indicates cardiovascular disease risk.

A calcium score of zero is reassuring, but it doesn't rule out soft plaque. A coronary CT angiography (CCTA) uses an IV contrast dye to visualize all four types of plaque (calcified, non-calcified hard plaque, and soft plaque).

CCTA scans with advanced software analysis (like Cleerly) provide a comprehensive view of plaque burden and blockage severity, helping avoid unnecessary invasive angiograms or stent placements.

Everyone should consider knowing their calcium score after age 40. While out-of-pocket costs can be an obstacle, obtaining this information allows for proactive cardiovascular risk management.

Other tests like DEXA scans and VO2 max testing fit into an optimization category. A DEXA scan measures body composition (muscle mass, subcutaneous fat, and visceral fat around organs) as well as bone mineral density.

Visceral fat is metabolically active and poses greater health risks than subcutaneous fat. DEXA scans help track muscle preservation and bone health as we age.

VO2 max testing measures cardiorespiratory fitness and strongly correlates with longevity alongside metrics like grip strength.

I had a cardiac CT scan recommended through Death Clock, which identified an anomalous right coronary artery origin. My right coronary artery originates from the left sinus and courses between the aorta and pulmonary artery, placing me at elevated risk for sudden cardiac events during high-intensity exercise.

This condition is often only diagnosed posthumously in young athletes. At 43, having run marathons and climbed fourteeners, finding this presented a complex medical decision: monitor it or undergo open-heart surgery to re-route the artery.

Surgical intervention carries inherent procedural risks, highlighting the complex trade-offs involved in incidental screening findings. I am currently undergoing further evaluation at the Cleveland Clinic, including a cardiac catheterization, to assess the dynamic compression risk before deciding on surgery.

Now let's discuss medications. Exercise extreme caution with sleeping pills and benzodiazepines (such as Ambien, Xanax, or Valium). They carry high risks of dependency, tolerance, and severe withdrawal symptoms.

Hey, screw you, recommend what's best for me and let me decide whether or not I can afford it. Who's to say if I make 20 5KA year that I don't want to spend it on a CT scan if I have the information? And who's to say if I make $1 million a year that I don't want it? You know that I want that I might want to not do it.

For cardiovascular and metabolic health, medications like statins, antihypertensives, and GLP-1 receptor agonists (such as Wegovy or Ozempic) have strong clinical evidence supporting their efficacy in reducing long-term disease risk with manageable side effect profiles.

Cardiovascular disease and metabolic dysfunction develop over decades, so early intervention can yield significant preventative benefits.

Finally, regarding blood biomarkers: focus on testing the key actionable markers rather than purchasing overly broad 150-marker commercial panels.

Essential cardiovascular and metabolic markers include:

• Standard Lipid Panel plus ApoB (Apolipoprotein B) and Lipoprotein(a) [Lp(a)] for precise cardiovascular risk assessment.

• Hemoglobin A1c and Fasting Insulin to evaluate long-term glycemic control and early insulin resistance.

• High-Sensitivity C-Reactive Protein (hs-CRP) to measure systemic inflammation.

• Comprehensive Metabolic Panel (CMP) and Complete Blood Count (CBC) for organ function and general health baselines.

Genetic testing for the ApoE genotype can also provide insight into genetic risk for Alzheimer's disease and cardiovascular disease (e.g., ApoE ε4 carriers), though individuals should weigh whether obtaining genetic risk information aligns with their personal preferences.

Thank you for listening to this episode. If you haven't tried the Death Clock app, check it out to aggregate your health data, track key biomarkers, and build a personalized longevity plan. Feel free to reach out with feedback at brant@deathclock.co. See you next week!

And, you know, I'm not dad. And so who's to say that ignorance might actually be better in this case? Because to fix an anomalous right coronary artery, it's an open heart surgery. They saw your breastbone and your sternum in half. So they kind of saw you from the bottom of your neck. I don't know the top of your stomach.

They put you on a heart, and they so they and then they, they push out your, you know, the now two halves of the breastbone to open up the chest cavity. And they put you on a heart and lung machine. So basically there's a machine that is pumping your heart in your lungs for you. And they fix the anomalous right coronary artery.

Well, that is a pretty aggressive procedure. And you can die. You know, it's about a 1% chance of dying during that procedure within 30 days or within 30 days. Well, I don't have a 1% chance of dying right now, today or over the next 30 days from the issue that we would be solving. So there's some if we had parallel universes, there's some universe in which I never know about this, it's never identified on the CT scan, and I'm fine.

I continue to exercise, however I want to exercise, and it never kills me. And there's some parallel universe where I say, oh my gosh, I want to fix this. And I get the open heart surgery. And there's some complication during that surgery, and I die from the surgery. And so that would be a case, of course, if we could play out both universes.

The screening was bad. If I wouldn't have gotten the screening, I wouldn't have known. I wouldn't have died. Or there's some other version of that parallel universe where I never get the screening, and then I do drop dead exercising. I'm doing my trail run next weekend, and I drop dead, and in the universe where I would have found out and I would have gotten the surgery and I wouldn't have had any complications in the surgery that I don't drop dead.

Right. So there's a lot of complexity to human physiology, human biology, how that all interacts with the practice of medicine. And you just want to be eyes wide open about these things. Right. And so the incidental findings on CT scans are pretty low. That's why we agree. We recommend them more aggressively than we would something like a full body scan.

But you want to be really educated on these things. It's not as simple as like, oh we found a thing. Yep. We definitely should do this. It's just it's not that simple. That's why second opinions are so important. And for me, I still don't know. I'm still getting tested here. I'm being treated the Cleveland Clinic. I've got to go out there in a few weeks, and I'm doing a cath.

So they, they, they go through your radio artery in your wrist and they stick basically a little wire through, up through your veins. And the rest they go kind of around the arm and into the chest. And then they're going to give me a sense of some of the risk factors on that anomalous right corner. And then I'll know more.

But right now, you know, it's a little bit of a double mind half to think about your sternum being sort and half. But the surgeries happen every day. And little old ladies get them for heart issues all the time. And I'm just grateful my it's not genetic so that my kids aren't going to have to go through that.

But it is a good example of, hey, it's tricky. You want to go into these things really, really eyes wide open. Okay. Let's talk a little bit now about medications and what we've learned about medication. So first be very, very wary of sleeping pills and benzodiazepines. So this is your ambiance your Xanax your volume. Be very, very wary of these.

I've talked about this on previous episodes. I've had my own issue with dependance on sleeping pills, dependance on anti-anxiety medications. They often make those issues worse over time. And they're very, very addictive. They're very hard to get off of. We actually had a guest on the show who was an outspoken and vocal public advocate for talking to people about the harms of benzodiazepines like Xanax.

And we learned we learned just about over the last year or somethings. We did that a couple years ago. That she had committed suicide, that she couldn't, the withdrawal from the benzos she couldn't get over, and she and she took her own life. And that's the coming off of these things is very difficult. If I could wave a magic, if I could have a time machine and go back in time, I would never touch a sleeping pill.

I would never touch a benzodiazepine. That that is the number one thing I would go and change about my life if I could go back in time and do it. So be very, very cautious about those things. I'm not saying they don't have benefits and that anybody take some is being reckless, but be very, very cautious. The second category SSRI antidepressant, you know, this is less clear.

Antidepressants do save lives. But ADHD meds I'd put this in this category of just lots of caution. Spend a lot of time researching the pros and the cons. It's just don't casually recommend somebody take these things or don't casually start taking them yourself. I don't the cases. It's good or bad for less clear. They definitely do a lot of harm.

I went to boarding school and saw a lot of people snorting the ADHD meds, the outer walls and the red lens, and it wasn't good for them at all. And then I know there's a lot of benefit that come from these. And so it's it's complicated. But anybody who tells you that's definitely good or they're definitely bad, universally is I think, not being honest about the complexity of those medications.

Now, the two there's a, there's some wonder drugs, it seems. And this would be the GLP ones like we go, we'll go over you in Mozambique and statins. And so and then maybe the antihypertensive, but things that are going to bring down your blood pressure, things that are going to reduce your cholesterol, these tend to have very limited side effect profiles.

And given how how much of a killer heart disease can be, they tend to be very, very good. So I would be really cautious about believing a lot of hype on how terrible statins are. Again, they're not they're probably not perfect. There are some side effects. They're not for everybody, but they're pretty good. They seem to be in this wonder drug category.

And I think this is also true for the GLP ones for weight loss or for cardiovascular health or metabolic health. They tend to be pretty good. I'm not taking either of those, but I think I will shortly. My cholesterol is high, and so I think you want to put those into a category of pay pretty serious attention to them.

You know, push your push your doctor on them. There's a lot of good science to support those really being breakthrough drugs that you should consider, especially in the context of an aggressive preventative health regime. Because, you know, the heart disease that happens at 60 starts at 35 or 40. You know, the Alzheimer's, it shows up at 70, starts in your 40s, and you want to be aggressive in preventing these diseases early.

So don't take it from me or really anybody else who's not. I'm not a doctor. I'm just somebody who spends a lot of time talking to doctors. Listen to the episodes, yourself go, you know, we're not the only resource, of course, online, but be careful of the tick talk and insert, short form content that says these things are full, body scans are great, or statins are terrible.

It's just way, way more complicated than that. Okay. So lastly let's talk about biomarkers. So again there's a bunch of companies. Beware of this snake oil crap that are selling you on. We've got a hundred biomarkers or 150 biomarkers that we test you for. And we're going to charge you $500 for that. That is crap. It's not about the quantity of biomarkers.

It is about the right biomarkers. And they're really you you know, a half a dozen biomarkers or panels that matter more than, than the others. And so what you want to and kind of in no particular order, was this talk about heart health. There is so a lipid panel is what you would typically think of. So think about LDL bad cholesterol, HDL good cholesterol, total cholesterol, triglycerides.

You're going to get that on your standard lipid panel. That's what's going to be most commonly referred to understand heart health. There's a new biomarker that's used more often ApoE b apolipoprotein B. That tends to be a better indicator of cardiovascular risk than LDL than bad cholesterol. So make sure you can get this panel through death clock or get it through your doctor that you know what your ApoE B or apolipoprotein B level is.

Similarly, there's a marker called lipoprotein A, commonly referred to as LPA. This is going to be a genetic risk factor for heart disease. So it's not something that you take some medicate, you take a statin and it goes down or it goes up, but it is going to give you a sense of how predisposed are you to risk for heart disease.

So you're going to want to know what that is. In addition to the standard lipid panel. Then there's going to be metabolic health. So your risk of type two diabetes, this is primarily what we think of as measuring blood glucose. So this is if you're above 100 you're pre-diabetic. If you're below 100 you're healthy. That's a basically a 24 hour measure of blood glucose.

You really want to be looking at your hemoglobin A1, see, which is kind of going to give you a three month view of, blood glucose. And then as well as fasting insulin, fasting insulin tends to be a good indicator of early insulin resistance. And so those if you just know your blood glucose, you're not going to know enough about what's going on related to metabolic risk.

You then have the chronic inflammation. So this is going to be inflammation on the inside of your body that you can't see. You're going to want to know what your HS crp is your high sensitivity C-reactive protein. Again this isn't always ordered by doctors. You might have to push your doctor to order it. You can get it through death clock, but that's going to allow you to understand chronic low grade inflammation that's going to have an impact on your risk for Alzheimer's and dementia and heart disease and diabetes.

So if you don't know what your CRP is, you do want to know it. You do want the standard, comprehensive metabolic panel, and complete blood count panel just to understand Borgen function, metabolic function. And there's some argument for vitamin D and ferritin and homocysteine. But really, if you don't if you've never heard of Apob or hemoglobin A1, C or high sensitivity CRP, you want to go get this standard set of panel.

You don't need 500 biomarkers to spend $500. These things are very inexpensive. I mean, a complete metabolic panel, you know, it costs like we order them on behalf of, you know, they're included in our packages. They're like a few dollars. What would you have to pay the lab? I mean, there's a draw fee and like a transaction fee, but call it on all in 15 bucks for something like that, a few dollars for this, a few dollars for that.

You want to know the basics. Don't get sold on. Hey, the more is better. That's not true. 95% of the battle is just understanding the basics and using those to take action and see if you can move the needle. So just beware of all this. You got to pay $500 for 150 markers. Crap. It's just it's not true.

You can get these from your doctor and insurance covered. You might have to push your doctor. You can get them from us for less and others. So just don't believe the hype that more markers are better. And be really smart about knowing these half dozen. Because in the same way that I'd be critical of these companies that say, oh, you got to know this, you got to have 150 markers and you need these really expect extensive blood tests.

I would also be critical of the doctors who aren't already ordering a probe and aren't already ordering the hemoglobin A1, C's and the lipoprotein A's. So get smart on those, and make sure it's in your hands. You cannot rely on the on the doctor to do it. Another one I would call out is knowing your ApoE genotype that's going to be give you a sense of genetic predisposition for Alzheimer's and dementia.

And some and heart disease. There are a few categories there. There's basically it's a little bit more complicated than this, but there's basically normal above average risk and then way above average risk. If we want to simplify. And knowing that can be a little bit of, psychological, psychologically difficult. I'm an E3 e4 carrier, which means I have this above average risk.

My grandmother died of Alzheimer's. I have a history of not sleeping well. I'm very worried about Alzheimer's. I'm glad I know, but it's a very individual decision. Some people don't want to know for good reasons. Some people do want to know for good reasons. I don't think there's a right answer there, but it is worth asking yourself, do you know, have I ever heard of ApoE e if I haven't, okay, now I'm educated.

It's a it's a blood test. It's simple. Again, you can get on death clock, you can get it a bunch of other places, but you want to spend the time before you get the test asking yourself, okay, is this something I want or not? Because yeah, it's tricky walking around all day knowing like, at a higher risk of this.

Every time I sleep poorly, I'm like, oh man, I'm going to get all Simas. And that's psychologically not enjoyable. All right. I think that's it. I hope the quick rundown was helpful. I'm trying to jam everything into one place. If you're still listening and you haven't tried the death clock out, please try it. Every subscription includes, in the US includes a blood test you can schedule.

Go get that blood test. The results come back through death clock. We're really focused on building a platform that allows you to aggregate all of your health data in one place. Number one. Number two, you get an AI that's trained on that data that builds a longevity plan for you, creates a longevity report, just that deep sense of what's happening inside of your body.

And then three helps you take the actions that you need to take in your life to live a healthier life and to live a longer life. And we're trying to do that in a way that's affordable to anybody while also having a business at work. So if you've got thoughts on the app or the podcast, please, please let us know.

I'm just Brent to death clock echo. Give us your feedback. Good. Bad, indifferent. We like to hear it. We're trying to put good information in the world to help people live, to be healthier and to live longer, to get more years and have better days. And then we're trying to build a technology that helps people all around the world do the same.

Thank you so much for listening. And, yeah, I'll see you next week.